Feverall Suppository
NDC Package 51672-2115-2
Package Information
Feverall (acetaminophen) suppositories is a medication used to treat mild to moderate pain (from headaches, menstrual periods, toothaches, backaches, osteoarthritis, or cold/flu aches and pains) and to reduce fever. This formulation utilizes a suppository delivery system. Marketed by Sun Pharmaceutical Industries, Inc., this product is identified by NDC 51672-2115 and is authorized under FDA application NDA018337.
Identification & Billing
- RxCUI: 198434 - acetaminophen 120 MG Rectal Suppository
- RxCUI: 198434 - APAP 120 MG Rectal Suppository
- RxCUI: 209353 - Feverall Children's 120 MG Rectal Suppository
- RxCUI: 209353 - acetaminophen 120 MG Rectal Suppository [Feverall]
- RxCUI: 209353 - APAP 120 MG Rectal Suppository [Feverall]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 51672 - Sun Pharmaceutical Industries, Inc.
- 51672-2115 - Feverall
- 51672-2115-2 - 6 BLISTER PACK in 1 CARTON / 1 SUPPOSITORY in 1 BLISTER PACK (51672-2115-0)
- 51672-2115 - Feverall
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (51672-2115). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 51672-2115-2 identifies a specific commercial package of 6 blister pack in 1 carton / 1 suppository in 1 blister pack (51672-2115-0) of Feverall Childrens, a human over the counter drug labeled by Sun Pharmaceutical Industries, Inc.. This suppository is formulated for rectal use and contains acetaminophen as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Sun Pharmaceutical Industries, Inc. on December 12, 2013. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
This drug is used to treat mild to moderate pain (from headaches, menstrual periods, toothaches, backaches, osteoarthritis, or cold/flu aches and pains) and to reduce fever.
How is this Sun Pharmaceutical Industries, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 51672211502. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 6 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.